Sildenafil Citrate Tablet, Film Coated
Product Images NDC 68071-3631

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 68071-3631). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3631 3)

Pdp (68071 3631 3)
This is a pharmaceutical product packaging label for Sildenafil 50mg tablets by Care Pharmaceuticals, Inc. It includes information such as the National Drug Code, lot number, expiration date, and dosage details. Patients are advised to consult their doctor regarding side effects and are provided with FDA reporting information. Additionally, storage instructions indicate the tablets should be kept out of reach of children and stored at a controlled temperature of 68-77°F.*
FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Sildenafil_fig1.jpg (Sildenafil Fig1)
This is a graph showing the mean change from baseline in sitting systolic blood pressure of healthy volunteers over time post-dose of Sildenafil 100mg and Placebo. The x-axis represents the time post-dose in hours, while the y-axis shows the systolic blood pressure in mmHg. The data appears to be collected at pre-dose, 4, 8, 12, 16, and 20 hours post-dose.*
FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

Sidenafil_fig_5 (Sildenafil Fig 5)
This text provides information about the mean sildenafil plasma concentrations in healthy male volunteers as shown in Figure 5.*
FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

Sildenafil-fig7 (Sildenafil Fig7)
Percentage patients reporting improvement in a study involving different treatments including Placebo, Sildenafil, and Sideral tablets. The data shows the percentage of patients who reported improvement after each treatment.*
FDA Label Image

Str (Sildenafil Structure)

FDA Label Image

Figure2 (Sildenafil Fig2)

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.